Insights

Reset

ADVI insights

Insights,

| Stacey Gilbert, MPH, MBA - Director, Precision Medicine

CRUSH and Genetic & Molecular Laboratories: A Potential Shift in Medicare Oversight

Insights,

| Stacey Gilbert, MPH, MBA - Director, Precision Medicine

March Is Colorectal Cancer Awareness Month: Why CMS’s Proposed NCD 210.3 Update Could Accelerate Patient‑Centered Screening Access

Insights,

| Marc Samuels, JD, MPH - Chief Executive Officer

MFN shifts from noise to credible threat

Insights,

| Marc Samuels, JD, MPH - Chief Executive Officer

The 2026 Rare Disease Reality
View All

Case Studies

Case Study: Turning IRA Policy into Portfolio and Pricing Strategy 

Case Study: Rare Disease State Policy Engagement

Case Study: Medicare Part D Liability Model 

Case Study: Strengthening Positioning for IRA Drug Price Negotiation
View All

Events

Events ADVI Health Attending AMCP 2026 in Nashville, TN
Events ADVI Health’s Alicia Silver at Tandem Meetings in Salt Lake City, UT
Events ADVI Health Attending ACCESS Forum US 2026
Events ADVI Health Attending ISPOR Europe 2025
Events ADVI Health Attending AMCP Nexus 2025
Events ADVI Health Experts Attending AVBCC 2025
View All

News

In The News ADVI Health’s Heidi De Souza Featured in Pharmacy Times
In The News ADVI Health’s Ashis Das Featured in First Report Managed Care
In The News ADVI Health Co-Authored Abstracted Featured at ASH Annual 2025
In The News ADVI Health’s Ashis Das Featured in Health Economics
In The News ADVI’s Alicia Silver Discusses the Cell and Gene Therapy Landscape with the Empowered Patient Podcast
In The News ADVI Health’s Lindsay Bealor Greenleaf Featured in Pink Sheet
View All

Videos

A Holiday Message from ADVI Health

ADVI Expert Shares Insight on Recent Policy Developments: OBBA, IRA Negotiation, and HRSA

ADVI Expert John Coster Shares Insights from ACCESS Forum 2025: Medicare Drug Pricing

ADVI Experts Lindsay Greenleaf and Alicia Silver Share Insight After ACCESS Forum 2025 Panels
View All